Add to ORKGLeukotrienes play a major role in the underlying pathophysiology of asthma. Leukotriene-receptor antagonists and direct leukotriene-synthesis inhibitors may be important new agents in maintenance therapy for asthma. Their role may also extend to attenuating exercise-induced and allergen-induced bronchospasm. This article reviews the effectiveness of available leukotriene modifiers in various clinical studies, reviews their adverse effects profile, and discusses their potential roles in the management of asthma
In persons with asthma, the cysteinyl leukotrienes possess multiple inflammatory properties in vitro...
Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course...
Leukotrienes play an important role in the pathogenesis of asthma, a chronic inflammatory disease. T...
This article briefly reviews the advances in our understanding of asthma with a particular focus on ...
The prevalence of asthma is increasing, especially among children. Despite the attention focused on ...
Asthma is a chronic inflammatory disease of the airways. Anti-inflammatory drug therapy, primarily u...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityAsthma is the most common respirato...
This article reviews the evidence for the involvement of leukotrienes in asthma and the effect of an...
Asthma is a chronic inflammatory disorder characterized by airflow obstruction. The development of l...
Leukotrienes (LTs) initiate a cascade of reactions that cause bronchoconstriction and inflammation i...
pproximately one third of all pre-scriptions for maintenance ther-apy in patients with persistent as...
AbstractVarious mediators of inflammation have been suggested as being important in the pathogenesis...
Leukotrienes, products of the 5-lipoxygenase pathway of arachidonic acid, are pro-inflammatory media...
Asthma is a serious world health problem characterised by a chronic inflammatory disorder of the air...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB(4) , are potent lipid mediators that ha...
In persons with asthma, the cysteinyl leukotrienes possess multiple inflammatory properties in vitro...
Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course...
Leukotrienes play an important role in the pathogenesis of asthma, a chronic inflammatory disease. T...
This article briefly reviews the advances in our understanding of asthma with a particular focus on ...
The prevalence of asthma is increasing, especially among children. Despite the attention focused on ...
Asthma is a chronic inflammatory disease of the airways. Anti-inflammatory drug therapy, primarily u...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityAsthma is the most common respirato...
This article reviews the evidence for the involvement of leukotrienes in asthma and the effect of an...
Asthma is a chronic inflammatory disorder characterized by airflow obstruction. The development of l...
Leukotrienes (LTs) initiate a cascade of reactions that cause bronchoconstriction and inflammation i...
pproximately one third of all pre-scriptions for maintenance ther-apy in patients with persistent as...
AbstractVarious mediators of inflammation have been suggested as being important in the pathogenesis...
Leukotrienes, products of the 5-lipoxygenase pathway of arachidonic acid, are pro-inflammatory media...
Asthma is a serious world health problem characterised by a chronic inflammatory disorder of the air...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB(4) , are potent lipid mediators that ha...
In persons with asthma, the cysteinyl leukotrienes possess multiple inflammatory properties in vitro...
Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course...
Leukotrienes play an important role in the pathogenesis of asthma, a chronic inflammatory disease. T...